drugset / Trial / NCT00107614
DT PACE, Tandem Autologous Transplant, Maintenance Therapy for Waldenstrom's Macroglobulinemia Patients
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to find out what the response is and the side effects are with chemotherapy using a combination of drugs called D.T. PACE (Dexamethasone, Thalidomide, cis-Platinum, Adriamycin, Cyclophosphamide, and Etoposide) + Rituxan, followed by two autologous transplants.
Timeline
- Start
- 2002-11
- Primary completion
- 2008-02
- Completion
- 2008-02
Outcome
Outcome not reported
Stopped (Enrollment): “Terminated due to poor accrual.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | — | — |
| Subject | Cyclophosphamide | Other / unclassified | — | — |
| Subject | Dexamethasone | Small molecule | — | — |
| Subject | Doxorubicin | Other / unclassified | — | — |
| Subject | Etoposide | Small molecule | — | — |
| Subject | Rituximab | Monoclonal antibody | — | — |
| Subject | Thalidomide | Other / unclassified | — | — |